Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page
- CheckyesterdayChange DetectedDifference0.5%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.6%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a Phase 2 trial for bardoxolone methyl and its associated criteria, while a new version number has been added.SummaryDifference28%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.